Quantitative analysis of transient DNA repair processes in vivo
Quantitative analysis of transient DNA repair processes in vivo
批准号:
9098814
负责人:
Eric Michael Brustad
金额:
$25.51万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-01 至 2018-05-31
关键词:
ATP phosphohydrolaseApoptosisBacteriaBase-Base MismatchBindingBiochemicalBiological ModelsBiological TestingCell SurvivalCell physiologyCellsCollaborationsComplexCoupledDNADNA BindingDNA DamageDNA LigasesDNA RepairDNA biosynthesisDNA-Directed DNA PolymeraseDNA-Protein InteractionDataDaughterDevelopmentDiseaseDouble Strand Break RepairEXO1 geneEmerging TechnologiesEukaryotaFluorescenceFluorescence Resonance Energy TransferFrequenciesFutureGenesGenetic RecombinationGoalsGrantHereditary Nonpolyposis Colorectal NeoplasmsHomologous GeneHumanImageIn VitroLabelLaboratoriesLicensingLifeLinkLocationMLH1 geneMSH2 geneMSH3 geneMSH6 geneMalignant NeoplasmsMethodsMismatch RepairMismatch Repair Gene InactivationModelingMolecularMonitorMultiprotein ComplexesMutagenesisMutationNucleotidesPMS2 geneProcessProkaryotic CellsPropertyProteinsPublished CommentRegulationRepair ComplexResistanceResolutionSaccharomyces cerevisiaeSamplingSeriesSignal TransductionSiteStagingStructure-Activity RelationshipSystemTechniquesTechnologyTreatment-Related CancerWorkYeastscancer therapychemotherapychromatin immunoprecipitationcytotoxicdimereffective therapyin vivoinsertion/deletion mutationinsightprotein protein interactionpublic health relevancerepairedresearch studysealsingle moleculesingle-molecule FRETspleen exonucleasestoichiometrytherapy designunnatural amino acidsyeast genetics
中文摘要
描述(由申请人提供):DNA错配修复(MMR)系统纠正复制过程中发生的DNA合成错误,并参与其他几项DNA交易。MMR是由MutS和MutL同源物启动的,它们在原核生物和真核生物中都高度保守。它们都是二聚体,都含有体内MMR所必需的DNA结合和ATPase活性。这些蛋白质的失活会导致更多的突变、不适当的重组,以及对几种DNA损伤剂的细胞毒性作用的抵抗。在人类中,错配修复基因的突变与遗传性非息肉病性结直肠癌(HNPCC)直接相关,并与几种散发性癌症有关。由于MMR蛋白功能的多样性,了解这些不同过程背后的分子机制将是至关重要的,以开发有效的治疗相关疾病和癌症的方法。在真核生物中,MutS?(MSH2-MSH6)和MutL?(酵母中的MLH1-PMS2,MLH1-Pms1)是启动MMR的主要MutS和MutL同源物。MutS?通过与错配结合并经历依赖于ATP的构象变化来启动修复,从而促进其与MutL?的相互作用。然后,增殖细胞核抗原激活MutL?,将女儿链切割成5‘和3’的错配。随后,MutS?激活5‘-3’外切酶EXO1,以过程地切除含有错误核苷酸的DNA。最后,DNA聚合酶催化重新合成,DNA连接酶封闭缺口。结构和生化研究,包括我们实验室的几项研究,表明蛋白质和蛋白质-DNA复合体的构象动力学和组装状态是MMR调控的中心。这一建议的总体目标是阐明在体内控制MMR启动的结构/功能关系。我们提出了一系列系统的实验,将我们灵敏的单分子荧光方法引入到以酿酒酵母为模型系统的活细胞中。我们将利用成熟的技术,如荧光蛋白质,以及快速崛起的技术,如非天然氨基酸标记。为了实现这个项目,我们组建了一个团队,他们在项目的各个方面都有很强的专业知识,而且对协作工作有很强的兴趣。此外,我们与托马斯·昆克尔博士的合作大大加强了我们执行该项目以及测试结果模型的生物学意义的能力。UR的目标是1)利用单分子荧光与超分辨技术相结合的技术,确定体内错配修复复合体的分子组成,包括蛋白质的化学计量和相对位置,以及2)使用单分子FRET检测错配修复起始蛋白MutS?和MutL?在修复过程中的体内构象动力学。拟议的实验将回答许多关于MMR分子机制的悬而未决的问题,并将扩大检测体内动力学和多蛋白复合体组成的技术范围。
英文摘要
DESCRIPTION (provided by applicant): The DNA mismatch repair (MMR) system corrects DNA synthesis errors that occur during replication and is also involved in several other DNA transactions. MMR is initiated by MutS and MutL homologs, which are highly conserved throughout prokaryotes and eukaryotes. They are both dimers and contain DNA binding and ATPase activities that are essential for MMR in vivo. Inactivation of these proteins leads to increased mutagenesis, improper recombination, and resistance to the cytotoxic effects of several DNA damaging agents. In humans, mutations in the mismatch repair genes are directly linked to hereditary non-polyposis colorectal cancer (HNPCC) and are associated with several sporadic cancers. Because of the diversity of functions carried out by the MMR proteins, it will be essential to understand the molecular mechanisms that underlie these different processes to develop effective treatment for the associated diseases and cancers. In eukaryotes, MutS¿ (MSH2-MSH6) and MutL¿ (MLH1-PMS2, Mlh1-Pms1 in yeast) are the primary MutS and MutL homologs responsible for initiation of MMR. MutS¿ initiates repair by binding to a mismatch and undergoing an ATP-dependent conformational change that promotes its interaction with MutL¿. PCNA then activates MutL¿ to incise the daughter strand both 5' and 3' to the mismatch. Subsequently, MutS¿ activates the 5'-3' exonuclease EXO1 to processively excise the DNA containing the incorrect nucleotide. Finally, DNA polymerase ¿ or ¿ catalyzes resynthesis, and DNA ligase seals the nick. Structural and biochemical studies, including several from our labs, indicate that the conformational dynamics and assembly states of the proteins and protein-DNA complexes are central to the regulation of MMR. The overall goal of this proposal is to elucidate the structure/function relationships that govern the initiation of MMR in vivo. We propose a systematic series of experiments that bring our sensitive single-molecule fluorescence methods to live cells using S. cerevisiae as a model system. We will take advantage of both established technologies, such as fluorescent proteins, as well as rapidly emerging technologies, such as unnatural amino acid labeling. To bring this project to fruition, we have assembled a team with both strong expertise in every aspect of the project and a strong penchant for collaborative work. In addition, our collaboration with Dr. Thomas Kunkel significantly strengthens our ability to carry out the project as well as to test the biological significance of the models that result. ur goals are 1) to determine the molecular compositions of in vivo mismatch repair complexes, including stoichiometries and relative locations of proteins, using single-molecule fluorescence coupled with super-resolution techniques, and 2) examine the in vivo conformational dynamics of the mismatch repair initiation proteins, MutS¿ and MutL¿, during repair using single-molecule FRET. The proposed experiments will answer many outstanding questions about the molecular mechanisms of MMR, and they will expand the range of techniques for examining the in vivo dynamics and compositions of multiprotein complexes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Origins of Ligand Binding and Selectivity in Methyllysine Reader and Writer Proteins
-
批准号:9309407
-
项目类别:
-
资助金额:$27.73万
-
财政年份:2017
-
负责人:Eric Michael Brustad
-
依托单位:
Quantitative analysis of transient DNA repair processes in vivo
-
批准号:8849464
-
项目类别:
-
资助金额:$25.55万
-
财政年份:2014
-
负责人:Eric Michael Brustad
-
依托单位:
Quantitative analysis of transient DNA repair processes in vivo
-
批准号:8667200
-
项目类别:
-
资助金额:$26.89万
-
财政年份:2014
-
负责人:Eric Michael Brustad
-
依托单位:
Evolution of cytochrome p450s for the diversification of drug scaffolds
-
批准号:7612437
-
项目类别:
-
资助金额:$4.52万
-
财政年份:2009
-
负责人:Eric Michael Brustad
-
依托单位:
Evolution of cytochrome p450s for the diversification of drug scaffolds
-
批准号:7787484
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2009
-
负责人:Eric Michael Brustad
-
依托单位:
Evolution of cytochrome p450s for the diversification of drug scaffolds
-
批准号:8214361
-
项目类别:
-
资助金额:$2.57万
-
财政年份:2009
-
负责人:Eric Michael Brustad
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: